CPT® Code 0332T

Myocardial sympathetic innervation imaging is a specialized diagnostic procedure that focuses on the sympathetic nervous system (SNS) innervation of the heart. This imaging technique employs radiolabeled metaiodobenzylguanidine (I-mIBG), a compound that mimics norepinephrine, to visualize and assess the distribution of cardiac nerves. The primary goal of this imaging is to evaluate the heart's sympathetic innervation, which is crucial for understanding various cardiac conditions. The procedure involves administering I-mIBG intravenously to the patient while they are at rest. Following the administration, imaging is conducted to capture both qualitative and quantitative data regarding the uptake of I-mIBG in the heart muscle. The assessment includes calculating the heart to mediastinum (H/M) ratio, which reflects the efficiency of norepinephrine reuptake by sympathetic neurons. This ratio is significant as it can indicate changes in sympathetic nerve activity, which may be associated with different disease processes and potential mortality risks. The imaging process incorporates both planar views and tomographic single-photon emission computed tomography (SPECT) to provide a comprehensive evaluation of heart function. The qualitative assessment involves visual interpretation of the images, while the quantitative analysis focuses on specific regions of interest to derive the H/M ratio. Ultimately, the physician interprets the findings, calculates the mIBG uptake ratio, and documents the results in a written report, contributing valuable information for patient management and treatment planning.